98213 Preventing Anthracycline Cardiovascular Toxicity with Statins (PREVENT) (1 credit)
Current Accrual: 21 out of 250 patients
Most Recent Protocol Documents (9)
Protocol • Site Consent • WF Consent* • Changes
Approval Letter • IND Exemption Letter
This study is open to any site with approved cardiac MRI capabilities. Please contact Sandra Soots (firstname.lastname@example.org) or Gina Enevold (email@example.com) with questions.
The participating sites are reminded to complete neurocognitive training prior to registering a patient. Bilingual staff must be certified to administer neurocognitive battery to non-English speaking patients.
*The most recent WF consent is the 2015 CR.
Administering a Neurocognitive Battery Videos